Hyrimoz and Humira are both medications that contain the same active ingredient, adalimumab.
Humira: This is the original brand name for adalimumab, which was first approved in 2002.
Hyrimoz: This is a biosimilar to Humira, meaning it is designed to be highly similar to Humira in terms of safety, efficacy, and quality, but it is marketed under a different name.
